⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 19, 2022Cell Reports MedicineOpen Access

Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses

Hiroshi Ishii Takushi Nomura Hiroyuki Yamamoto Masako Nishizawa Trang Thi Thu Hau Shigeyoshi Harada Sayuri Seki Midori Nakamura‐Hoshi Midori Okazaki Sachie Daigen Ai Kawana‐Tachikawa Noriyo Nagata Naoko Iwata‐Yoshikawa Nozomi Shiwa Tadaki Suzuki Eun‐Sil Park Ken Maeda Taishi Onodera Yoshimasa Takahashi Kohji Kusano Ryutaro Shimazaki Yuriko Suzaki Yasushi Ami Tetsuro Matano

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

T cell responses to contribute to COVID-19 containment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ishii et al. (2022) studied this question.

synapsesocial.com/papers/6a5ed3bbb7d7f004ae5905db https://doi.org/10.1016/j.xcrm.2022.100520

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The implications of silent transmission for the control of COVID-19 outbreaksOriginal Research · 2020 · 449 citations
2Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 14,591 citations
3Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineClinical Trial · 2020 · 10,119 citations
4Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKRCT · 2020 · 4,615 citations
5Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19RCT · 2021 · 2,398 citations

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies2020
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera2021
SARS-CoV-2 Variants and Vaccines2021
Multi-omics-driven personalized management of advanced HCCCell Reports Medicine · 2026
Enhanced liver regeneration via targeted mRNA delivery for partial in vivo reprogrammingCell Reports Medicine · 2026

More from Cell Reports Medicine

More from Kumamoto University

More from National Institute of Infectious Diseases

More from ID Pharma (Japan)